IJCS | Volume 31, Nº6, November / December 2018

568 1. Godinho RR, Ribeiro HB, Faig S, Spadaro AG, Gabrilaitis C, Sacramento G, et al. Comparação das vias radial e femoral nas intervenções coronárias percutâneas: Resultados do registro TotalCor. Rev Bras Cardiol Invasiva. 2011;19(3):272-8. 2. Ndrepepa G, Neumann FJ, Richardt G, Schulz S, Tölg R, Stoyanov KM, et al. Prognostic value of access and non-access sites bleeding after percutaneous coronary intervention. Circ Cardiovasc Interv. 2013;6(4):354–61. 3. Bianchi R, D’Acierno L, Crisci M, Tartaglione D, Cappelli Bigazzi M, Canonico M, et al. From femoral to radial approach in coronary intervention: reviewof the literature and 6 years single-center experience. Angiology.2017;68(4):281-7. 4. Chase AJ, Fretz EB, Warburton WP, Klinke WP, Carere RG, Pi D, et al. Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart. 2008;94(8):1019–25. 5. Ferrante G, Rao S V, Jüni P, Da Costa BR, Reimers B, Condorelli G, et al. Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease. A meta-analysis of randomized trials. JACC Cardiovasc Interv. 2016;9(14):1419-34. 6. HillegassW. Themany radial access learning curves. Catheter Cardiovasc Interv. 2017;89(5):865-6. 7. Wimmer NJ,Resnic F, Mauri L, MatheneyME, Piemonte TC, Pomerantsey E, et al. Risk-treatment paradox in the selection of transradial access for percutaneous coronary intervention. J AmHeart Assoc. 2013;2(3):e000174 8. Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (CanRapid risk stratification of Unstable angina patients Suppress Adverse outcomes with Early implementation of the ACC/AHAGuidelines) Bleeding Score. Circulation. 2009;119(14):1873-82. 9. Mehran R, Pocock S, Nikolski E, CClayton T, Dangas GD, Kirtane AJ, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010; 55(23): 2556-66. 10. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem. 2003;49(8):1331-6. 11. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736-47. 12. Demidenko E. Sample size and optimal design for logistic regression with binary interaction. Stat Med. 2008;27(1):36-46. 13. Bornstein BH, Emler AC. Rationality in medical decision making: a review of the literature on doctors’decision-making biases. J Evaluat Clin Pract. 2001; 7(2): 97-107. 14. Silva G. O processo de tomada de decisão na prática clínica: a medicina como estado da arte. Rev Bras Clin Med. São Paulo, 2013 jan-mar; 11(1): 75-9. 15. Hall KH. Reviewing intuitive decision-making and uncertainty: the implications for medical education. Med Educ. 2002;36(3):216-24. 16. Watanabe E. Risk-treatment paradox of anticoagulation therapy in atrial fibrillation. Circ J. 2014;78(9):2146-8. 17. Roe MT, Peterson ED, Newby LK, Chen AY, Pollack C , Brindis RG, et al. The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J. 2006;151(6):1205-13. 18. Birkemeyer R, Schneider H, Rillig A, Ebeling J, Akin I, Kische S, et al. Do gender differences in primary PCI mortality represent a different adherence to guideline recommended therapy? a multicenter observation. BMC Cardiovasc Disord. 2014; Jan 2,144:71. 19. LimYH,LeeY,ShinJ,YoonJ,LeeSH,RhaSW,etal.Comparisonsofclinical andproceduraloutcomesbetweentransradialandtransfemoralapproaches in percutaneous coronary intervention (from the Korean Transradial Intervention Prospective Registry). Am J Cardiol.2016;117(8):1272-81. 20. Kilic S, Hermanides RS, Ottervanger JP, Kolkman E, Dambrink JHE, Roolvink V, et al. Effects of radial versus femoral artery access in patients with acute myocardial infarction: A large centre prospective registry. Neth Heart J. 2017;25(1):33-9. 21. Yan AT, Yan RT, Tan M, Casanova A, Labinaz M, Sridhar K, et al. Risk scores for risk stratification in acute coronary syndromes: Useful but simpler is not necessarily better. Eur Heart J. 2007;28(9):1072–8. 22. Weintraub WS. Prediction scores after myocardial infarction: Value, limitations, and future directions. Circulation. 2002;106(18):2292–3. References Lacerda et al. Paradoxical choice for radial access in ACS Int J Cardiovasc Sci. 2018;31(6)562-568 Original Article This is an open-access article distributed under the terms of the Creative Commons Attribution License

RkJQdWJsaXNoZXIy MjM4Mjg=